Allele Biotechnology & Pharmaceuticals, Inc.
- Sector
- Biotech
- Headquarters
- CA
- Latest Form D
- $11M, Oct 2016
- Total capital
- $18M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $18M
- 2 Form D · last Oct 2016
- 120 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 6
- 5 pending · first 2017
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$11M
- Private capital raisedForm D · SEC · 1st filing$7M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
Researcher links verified by same-company patents and grants- Jiwu WangResearcherExecutive Officer, DirectorLinked by 5 patents
- Lin YangExecutive OfficerNamed in SEC Form D filings
- Quishi FuDirectorNamed in SEC Form D filings
- Robert LaPollaDirectorNamed in SEC Form D filings
- Shao-Chung TsaiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 6 granted of 11- GrantedMethods Of Selecting Antibodies And Antibody FragmentsUSPTOUS 12,404,552
- GrantedLight-absorbing Compositions And Methods Of UseUSPTOUS 10,842,728
- GrantedFeeder-free Derivation Of Human-induced Pluripotent Stem Cells With Synthetic Messenger RnaUSPTOUS 10,435,711
Show all 11 patent records
- Methods Of Selecting Antibodies And Antibody FragmentsSep 2, 2025 · US 12,404,552Granted
- Light-absorbing Compositions And Methods Of UseNov 24, 2020 · US 10,842,728Granted
- Feeder-free Derivation Of Human-induced Pluripotent Stem Cells With Synthetic Messenger RnaOct 8, 2019 · US 10,435,711Granted
- Novel Monomeric Yellow-green Fluorescent Protein From CephalochordateMar 5, 2019 · US 10,221,221Granted
- Feeder-free Derivation Of Human-induced Pluripotent Stem Cells With Synthetic Messenger RnaNov 6, 2018 · US 10,119,150Granted
- Light-absorbing Compositions And Methods Of UseAug 22, 2017 · US 9,737,472Granted
- Multi-pathway Induction Of Stem Cell Differentiation Wtih RnaApplication 62163648Pending
- Induction Of Hepatocytes By Stem Cell Differentiation With RnaApplication PCTUS2017062102Pending
- Compositions And Methods For Peptide-assisted TransfectionApplication PCTUS2004021144Pending
- Induction Of Pancreatic Beta Cells By Stem Cell Differentiation With RnaApplication PCTUS2017062105Pending
- Light-absorbing Compositions And Methods Of UseApplication PCTUS2018047390Pending
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .